Physician profile

Timothy Hunter

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Augusta, GA

NPI 1538268487

$21,730.70

in general payments reported to CMS, 2019-2025

35 companies · $1,520 in 2025

The $1,520 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,484.21

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $14,648.78 2019-2025 Thoratec Heartmate 3 Lvas Implant Kit, Epic, 2nd Gen Centrimag Primary Console
Edwards Lifesciences Corporation $2,974.10 2019-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Mitris Resilia Mitral Valve
Atricure, INC. $1,293.34 2019-2025 Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System
Abiomed $476.12 2024-2025 Impella
Getinge USA Sales, LLC $440.43 2019-2025 Vasoview Hemopro 2, Cardiosave Rescue, Cardioroot
Terumo Cardiovascular Systems Corporation $190.06 2019-2020
Baxter Healthcare $188.82 2019-2025 Tisseel, Preveleak
Ethicon US, LLC $181.63 2019-2025 Surgicel Nu-Knit, Vistaseal, Prolene
Lsi Solutions INC $128.84 2021-2025 Cor-Knot, Cor Knot, Minirumel
Artivion, INC. $126.79 2019-2024 On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cardiac Non-Synergraft
Boston Scientific Corporation $103.91 2020-2025 General - Therapies, Varithena Administration Pack
Davol INC. $99.59 2022-2025 Progel Applicator Spray Tips, Arista
Cvrx, INC. $94.40 2024-2025 Barostim Neo System
Stryker Corporation $90.81 2021-2024 Spy-Phi System
Lemaitre Vascular, INC. $88.04 2020
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Inari Medical, INC. $72.70 2022
Medtronic Vascular, INC. $52.54 2019-2020
Livanova USA, INC. $51.85 2021
Haemonetics Corporation $39.51 2024-2025 Teg5000 Hemostasis Analyzer
Medtronic, INC. $38.65 2025 Penditure, Corevalve Evolut R
Zimmer Biomet Holdings, INC. $37.54 2025 Sternalock 360 System, Sternalock
Convatec INC. $33.64 2021
Janssen Pharmaceuticals, INC $31.78 2019-2022
E.R. Squibb & Sons, L.L.C. $29.39 2022
Hemosonics LLC $28.64 2022
Depuy Synthes Sales INC. $26.86 2020
Team 1, LLC $24.59 2024
Olympus America INC. $21.06 2022
Angiodynamics, INC. $19.48 2022
Pfizer INC. $17.99 2019
Actelion Pharmaceuticals US, INC. $17.98 2019
Teleflex LLC $17.17 2021
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $16.53 2019
Bolton Medical INC $16.18 2020
Cook Medical LLC $10.96 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Timothy Hunter

$21,730.70

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $1,520 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/341994/timothy-hunter

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.